EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility



In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility



Letters in Applied Microbiology 47(4): 309-314




(PDF emailed within 0-6 h: $19.90)

Accession: 022818546

Download citation: RISBibTeXText

DOI: 10.1111/j.1472-765x.2008.02423.x



Related references

In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. Letters in Applied Microbiology 47(4): 309-314, 2009

In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. Journal of Antimicrobial ChemoTherapy 46(6): 905-908, 2000

In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study. Mikrobiyoloji Bulteni 41(1): 1-9, 2007

In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities. Clinical Microbiology and Infection 9(7): 704-707, 2003

Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. Antimicrobial Agents and ChemoTherapy 45(11): 3242-3245, 2001

Activity of ceftibuten, cefaclor, azithromycin, clarithromycin, erythromycin and telithromycin against Streptococcus pyogenes clinical isolates with different genotypes and phenotypes. ChemoTherapy 51(5): 268-271, 2005

Activity of telithromycin against erythromycin-susceptible and resistant isolates of Streptococcus pneumoniae and S pyogenes from Austria. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 176, 2000

Activity of telithromycin against isolates of Streptococcus pneumoniae and Streptococcus pyogenes collected from pediatric patients in Austria. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 191, 2001

Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae. Journal of Antimicrobial ChemoTherapy 59(6): 1171-1176, 2007

Activity of telithromycin against clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from pediatric patients in Great Britain Ireland. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 167, 2002

PROTEKT USY4: Activity of telithromycin against isolates of Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae from across the USA in 2003-2004. 2005

In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis. Journal of Antimicrobial ChemoTherapy 50(1): 145-148, 2002

In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children. International Journal of Antimicrobial Agents 18(6): 531-535, 2001

In vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae and Streptococcus agalactiae. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 176, 2000